Literature DB >> 17626169

Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars.

Jane F Turton1, Nazia Arif, Daneeta Hennessy, Mary E Kaufmann, Tyrone L Pitt.   

Abstract

One hundred thirty-eight clinical isolates of the Burkholderia cepacia complex (Bcc) were identified using a modified strategy that involved PCR detection of the cblA gene for the ET12 lineage simultaneously with detection of the Bcc recA PCR product; recA sequence cluster analysis also was part of the strategy. Four strains could not be assigned to any of the known genomovars.

Mesh：

Substances：

Year:  2007        PMID： 17626169      PMCID： PMC2045300          DOI： 10.1128/JCM.00976-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.

Authors:  Leslie A Kalish; David A Waltz; Mark Dovey; Gail Potter-Bynoe; Alexander J McAdam; John J Lipuma; Craig Gerard; Donald Goldmann
Journal:  Am J Respir Crit Care Med       Date:  2005-11-04       Impact factor: 21.405

Review 2.  Update on the Burkholderia cepacia complex.

Authors:  John J Lipuma
Journal:  Curr Opin Pulm Med       Date:  2005-11       Impact factor: 3.155

3.  Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans.

Authors:  Emma Caraher; Caroline Duff; Tracy Mullen; Suzanne Mc Keon; Philip Murphy; Máire Callaghan; Siobhán McClean
Journal:  J Cyst Fibros       Date:  2006-06-15       Impact factor: 5.482

4.  Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom.

Authors:  F E Clode; M E Kaufmann; H Malnick; T L Pitt
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.

Authors:  Pavel Drevinek; Sarka Vosahlikova; Ondrej Cinek; Vera Vavrova; Jana Bartosova; Petr Pohunek; Eshwar Mahenthiralingam
Journal:  J Med Microbiol       Date:  2005-07       Impact factor: 2.472

6.  Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.

Authors:  E Mahenthiralingam; P Vandamme; M E Campbell; D A Henry; A M Gravelle; L T Wong; A G Davidson; P G Wilcox; B Nakielna; D P Speert
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

7.  Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe.

Authors:  T Coenye; T Spilker; A Van Schoor; J J LiPuma; P Vandamme
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

8.  Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.

Authors:  Peter Vandamme; Deborah Henry; Tom Coenye; Sazini Nzula; Marc Vancanneyt; John J LiPuma; David P Speert; John R W Govan; Eshwar Mahenthiralingam
Journal:  FEMS Immunol Med Microbiol       Date:  2002-06-03

9.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.

Authors:  L Sun; R Z Jiang; S Steinbach; A Holmes; C Campanelli; J Forstner; U Sajjan; Y Tan; M Riley; R Goldstein
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

10.  Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis.

Authors:  Rhiannon Biddick; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  FEMS Microbiol Lett       Date:  2003-11-07       Impact factor: 2.742
View more
  5 in total

1.  Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex.

Authors:  Karlene H Lynch; Jonathan J Dennis
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

2.  Identification of isolates within the Burkholderia cepacia complex by a multiplex recA and 16S rRNA gene real-time PCR assay.

Authors:  Jason D Pimentel; Sally M Dubedat; Evan L N Dodds; Richard A V Benn
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

3.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

4.  Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.

Authors:  Tiffany Mott; Michael Soler; Sierrah Grigsby; Ronald Medley; Gregory C Whitlock
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.

Authors:  Pamela Vernocchi; Federica Del Chierico; Alessandra Russo; Fabio Majo; Martina Rossitto; Mariacristina Valerio; Luca Casadei; Antonietta La Storia; Francesca De Filippis; Cristiano Rizzo; Cesare Manetti; Paola Paci; Danilo Ercolini; Federico Marini; Ersilia Vita Fiscarelli; Bruno Dallapiccola; Vincenzina Lucidi; Alfredo Miccheli; Lorenza Putignani
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.